Events | Splenectomy | Romiplostim | Rituximab | Corticosteroids |
---|---|---|---|---|
Efficacy rates | 76.1% [15] | 84.1% [14] | ― | |
Relapse rates | 0.45% [3] | 0%* | 0.88% [18] | ― |
Adverse event rates | 0.44% [13] | 0.58% [14] | 0.24% [7] | 11% [19] |
Emergency treatment rates (PL < 30 × 109/L) | 14.4% [20] | 14.4% [20] | 14.4% [20] | 26.8% [20] |
Emergency treatment rates (PL ≥ 30 × 109/L) | 0.4% [20] | 0.4% [20] | 0.4% [20] | ― |
Mortality rate (PL < 30 × 109/L) | ||||
Mortality rate (PL ≥ 30 × 109/L) |